• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法国 2006-2015 年 30223 例组织病理学证实的脑膜瘤的描述性流行病学研究。

Descriptive epidemiology of 30,223 histopathologically confirmed meningiomas in France: 2006-2015.

机构信息

Department of Neurosurgery, Hôpital Privé Clairval - Ramsay Santé, 317 Bd de Redon, 13009, Marseille, France.

Department of Neurosurgery, Gui de Chauliac Hospital, Montpellier University Medical Center, 34295, Montpellier cedex 5, France.

出版信息

Acta Neurochir (Wien). 2024 May 14;166(1):214. doi: 10.1007/s00701-024-06093-z.

DOI:10.1007/s00701-024-06093-z
PMID:38740641
Abstract

BACKGROUND AND OBJECTIVES

Meningioma is one of the most common neoplasm of the central nervous system. To describe the epidemiology of meningioma operated in France and, to assess grading and histopathological variability among the different neurosurgical centres.

METHODS

We processed the French Brain Tumour Database (FBTDB) to conduct a nationwide population-based study of all histopathologically confirmed meningiomas between 2006 and 2015.

RESULTS

30,223 meningiomas cases were operated on 28,424 patients, in 61 centres. The average number of meningioma operated per year in France was 3,022 (SD ± 122). Meningioma was 3 times more common in women (74.1% vs. 25.9%). The incidence of meningioma increased with age and, mean age at surgery was 58.5 ± 13.9 years. Grade 1, 2, and 3 meningiomas accounted for 83.9%, 13.91% and, 2.19% respectively. There was a significant variability of meningioma grading by institutions, especially for grade 2 which spanned from 5.1% up to 22.4% (p < 0.001). Moreover, the proportion of grade 2 significantly grew over the study period (p < 0.001). There was also a significant variation in grade 1 subtypes diagnosis among the institutions (p < 0.001). 89.05% of the patients had solely one meningioma surgery, 8.52% two and, 2.43% three or more. The number of surgeries was associated to the grade of malignancy (p < 0.001).

CONCLUSION

The incidence of meningioma surgery increased with age and, peaked at 58.5 years. They were predominantly benign with meningothelial subtype being the most common. However, there was a significant variation of grade 1 subtypes diagnosis among the centres involved. The proportion of grade 2 meningioma significantly grew over the study time, on contrary to malignant meningioma proportion, which remained rare and, stable over time around 2%. Likewise, there was a significant variability of grade 2 meningioma rate among the institutions.

摘要

背景与目的

脑膜瘤是中枢神经系统最常见的肿瘤之一。本研究旨在描述法国脑膜瘤的流行病学特征,并评估不同神经外科中心的分级和组织病理学变异性。

方法

我们对法国脑肿瘤数据库(FBTDB)进行了处理,对 2006 年至 2015 年间所有经组织病理学证实的脑膜瘤进行了全国范围内的基于人群的研究。

结果

在 61 个中心共对 28424 例患者的 30223 例脑膜瘤病例进行了手术。法国每年平均手术切除的脑膜瘤数量为 3022 例(标准差±122)。女性脑膜瘤的发病率是男性的 3 倍(74.1% vs. 25.9%)。脑膜瘤的发病率随年龄增长而增加,手术时的平均年龄为 58.5±13.9 岁。1 级、2 级和 3 级脑膜瘤分别占 83.9%、13.91%和 2.19%。不同机构的脑膜瘤分级存在显著差异,特别是 2 级脑膜瘤,从 5.1%到 22.4%不等(p<0.001)。此外,在研究期间,2 级脑膜瘤的比例显著增加(p<0.001)。不同机构诊断的 1 级亚型也存在显著差异(p<0.001)。89.05%的患者仅进行了一次脑膜瘤手术,8.52%的患者进行了两次手术,2.43%的患者进行了三次或更多次手术。手术次数与恶性程度相关(p<0.001)。

结论

脑膜瘤手术的发病率随年龄增长而增加,在 58.5 岁时达到高峰。脑膜瘤主要为良性,脑膜上皮型最常见。然而,不同中心之间 1 级亚型的诊断存在显著差异。2 级脑膜瘤的比例在研究期间显著增加,而恶性脑膜瘤的比例则相对较少且保持稳定,约为 2%。同样,不同机构的 2 级脑膜瘤发生率也存在显著差异。

相似文献

1
Descriptive epidemiology of 30,223 histopathologically confirmed meningiomas in France: 2006-2015.法国 2006-2015 年 30223 例组织病理学证实的脑膜瘤的描述性流行病学研究。
Acta Neurochir (Wien). 2024 May 14;166(1):214. doi: 10.1007/s00701-024-06093-z.
2
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.
3
Perifocal edema is a risk factor for preoperative seizures in patients with meningioma WHO grade 2 and 3.瘤周水肿是 WHO 分级为 2 级和 3 级脑膜瘤患者术前癫痫发作的一个危险因素。
Acta Neurochir (Wien). 2024 Apr 6;166(1):170. doi: 10.1007/s00701-024-06057-3.
4
Aural toilet (ear cleaning) for chronic suppurative otitis media.慢性化脓性中耳炎的耳道清理(耳部清洁)
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013057. doi: 10.1002/14651858.CD013057.pub3.
5
Use of β-adrenoreceptor drugs and Parkinson's disease incidence in women from the French E3N cohort study.来自法国E3N队列研究的女性中β-肾上腺素能受体药物的使用与帕金森病发病率
J Parkinsons Dis. 2025 Apr 29:1877718X251330993. doi: 10.1177/1877718X251330993.
6
Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial.奥贝胆酸治疗 Alagille 综合征患者的疗效和安全性(ASSERT):一项 3 期、双盲、随机、安慰剂对照试验。
Lancet Gastroenterol Hepatol. 2024 Jul;9(7):632-645. doi: 10.1016/S2468-1253(24)00074-8. Epub 2024 Apr 23.
7
Descriptive epidemiology of 399 histologically confirmed newly diagnosed meningeal solitary fibrous tumours and haemangiopericytomas in France: 2006-2015.法国 2006-2015 年 399 例组织学证实的新诊断脑膜孤立性纤维瘤和血管外皮细胞瘤的描述性流行病学研究。
Acta Neurochir (Wien). 2024 Aug 2;166(1):320. doi: 10.1007/s00701-024-06191-y.
8
Non-pharmacological interventions for sleep promotion in hospitalized children.促进住院儿童睡眠的非药物干预措施。
Cochrane Database Syst Rev. 2022 Jun 15;6(6):CD012908. doi: 10.1002/14651858.CD012908.pub2.
9
Transcarotid Artery Revascularization Learning Curves Differ between Surgeon Experience Level.经颈动脉血管重建术的学习曲线因外科医生的经验水平而异。
Ann Vasc Surg. 2025 Apr;113:346-352. doi: 10.1016/j.avsg.2024.07.126. Epub 2024 Sep 26.
10
Absorbent products for moderate-heavy urinary and/or faecal incontinence in women and men.适用于女性和男性中重度尿失禁和/或大便失禁的吸收性产品。
Cochrane Database Syst Rev. 2008 Oct 8(4):CD007408. doi: 10.1002/14651858.CD007408.

引用本文的文献

1
Meningiomas in Rubinstein-Taybi syndrome: A case report and comprehensive review.鲁宾斯坦-泰比综合征中的脑膜瘤:一例报告及综合综述
J Neuropathol Exp Neurol. 2025 Apr 1;84(4):329-336. doi: 10.1093/jnen/nlae135.
2
Descriptive epidemiology of 399 histologically confirmed newly diagnosed meningeal solitary fibrous tumours and haemangiopericytomas in France: 2006-2015.法国 2006-2015 年 399 例组织学证实的新诊断脑膜孤立性纤维瘤和血管外皮细胞瘤的描述性流行病学研究。
Acta Neurochir (Wien). 2024 Aug 2;166(1):320. doi: 10.1007/s00701-024-06191-y.

本文引用的文献

1
Is brain invasion sufficient as a stand-alone criterion for grading atypical meningioma?脑侵犯作为非典型脑膜瘤分级的独立标准是否足够?
J Neurosurg. 2023 Mar 31;139(4):953-964. doi: 10.3171/2023.2.JNS222751. Print 2023 Oct 1.
2
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015-2019.美国 2015-2019 年确诊的原发性脑和其他中枢神经系统肿瘤 CBTRUS 统计报告。
Neuro Oncol. 2022 Oct 5;24(Suppl 5):v1-v95. doi: 10.1093/neuonc/noac202.
3
Clinical and pathological impact of an optimal assessment of brain invasion for grade 2 meningioma diagnosis: lessons from a series of 291 cases.
291 例脑膜瘤病例系列研究得出的关于最佳评估脑膜瘤脑侵犯对 2 级脑膜瘤诊断的临床和病理影响的经验教训。
Neurosurg Rev. 2022 Aug;45(4):2797-2809. doi: 10.1007/s10143-022-01792-6. Epub 2022 Apr 29.
4
Functional Outcome After Spinal Meningioma Surgery. A Nationwide Population-Based Study.脊髓脑膜瘤手术后的功能结局。一项基于全国人口的研究。
Neurospine. 2022 Mar;19(1):96-107. doi: 10.14245/ns.2143186.593. Epub 2022 Mar 31.
5
Epidemiology and Survival after Spinal Meningioma Surgery: A Nationwide Population-Based Study.脊髓膜瘤手术后的流行病学与生存率:一项基于全国人口的研究。
Asian Spine J. 2022 Dec;16(6):865-873. doi: 10.31616/asj.2021.0213. Epub 2022 Jan 24.
6
Postoperative Adjuvant Radiotherapy in Atypical Meningioma Patients: A Meta-Analysis Study.非典型脑膜瘤患者的术后辅助放疗:一项荟萃分析研究
Front Oncol. 2021 Dec 2;11:787962. doi: 10.3389/fonc.2021.787962. eCollection 2021.
7
Five-year cause-specific survival after meningioma surgery. A nationwide population-based study.脑膜瘤手术后的 5 年特定病因生存情况。一项全国范围内基于人群的研究。
Neurochirurgie. 2022 Apr;68(3):280-288. doi: 10.1016/j.neuchi.2021.11.003. Epub 2021 Dec 11.
8
Outcome After Protontherapy for Progression or Recurrence of Surgically Treated Meningioma.手术治疗的脑膜瘤进展或复发后质子治疗的结果
Brain Tumor Res Treat. 2021 Oct;9(2):46-57. doi: 10.14791/btrt.2021.9.e9.
9
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.2021 年世卫组织中枢神经系统肿瘤分类:概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
10
Cyproterone acetate and meningioma: a nationwide-wide population based study.醋酸环丙孕酮与脑膜瘤:一项全国范围内基于人群的研究。
J Neurooncol. 2021 Jan;151(2):331-338. doi: 10.1007/s11060-020-03672-9. Epub 2021 Jan 4.